309 related articles for article (PubMed ID: 30558196)
1. Radiotherapy as a New Player in Immuno-Oncology.
Wang SJ; Haffty B
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558196
[TBL] [Abstract][Full Text] [Related]
2. Advances in Radiotherapy Immune Modulation: From Bench-to-Bedside and Back Again.
Wang CX; Hunt J; Feinstein S; Kim SK; Monjazeb AM
Surg Oncol Clin N Am; 2023 Jul; 32(3):617-629. PubMed ID: 37182996
[TBL] [Abstract][Full Text] [Related]
3. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.
Marciscano AE; Walker JM; McGee HM; Kim MM; Kunos CA; Monjazeb AM; Shiao SL; Tran PT; Ahmed MM
J Immunother Cancer; 2018 Jan; 6(1):6. PubMed ID: 29375032
[TBL] [Abstract][Full Text] [Related]
4. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
Grapin M; Richard C; Limagne E; Boidot R; Morgand V; Bertaut A; Derangere V; Laurent PA; Thibaudin M; Fumet JD; Crehange G; Ghiringhelli F; Mirjolet C
J Immunother Cancer; 2019 Jun; 7(1):160. PubMed ID: 31238970
[TBL] [Abstract][Full Text] [Related]
5. Awakening the immune system with radiation: Optimal dose and fractionation.
Gandhi SJ; Minn AJ; Vonderheide RH; Wherry EJ; Hahn SM; Maity A
Cancer Lett; 2015 Nov; 368(2):185-90. PubMed ID: 25799953
[TBL] [Abstract][Full Text] [Related]
6. The Role of Radiation Oncology in Immuno-Oncology.
Meng X; Feng R; Yang L; Xing L; Yu J
Oncologist; 2019 Feb; 24(Suppl 1):S42-S52. PubMed ID: 30819830
[TBL] [Abstract][Full Text] [Related]
7. [Combining radiotherapy with immunotherapy for urological malignancies].
Rieken S; El Shafie R
Urologe A; 2018 Nov; 57(11):1309-1315. PubMed ID: 30324394
[TBL] [Abstract][Full Text] [Related]
8. The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers.
Saidian A; Dolendo I; Sharabi A; Stewart TF; Rose B; McKay RR; Bagrodia A; Salmasi A
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612124
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy and Radiation: Charting a Path Forward Together.
Sridharan V; Schoenfeld JD
Hematol Oncol Clin North Am; 2019 Dec; 33(6):1057-1069. PubMed ID: 31668206
[TBL] [Abstract][Full Text] [Related]
10. Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.
Solanki AA; Bossi A; Efstathiou JA; Lock D; Mondini M; Ramapriyan R; Welsh J; Kang J
Eur Urol Oncol; 2019 Feb; 2(1):79-87. PubMed ID: 30929848
[TBL] [Abstract][Full Text] [Related]
11. Lattice radiation therapy - its concept and impact in the immunomodulation cancer treatment era.
Pellizzon ACA
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):728-731. PubMed ID: 32696876
[TBL] [Abstract][Full Text] [Related]
12. Combining PARP inhibition, radiation, and immunotherapy: A possible strategy to improve the treatment of cancer?
Césaire M; Thariat J; Candéias SM; Stefan D; Saintigny Y; Chevalier F
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30487462
[TBL] [Abstract][Full Text] [Related]
13. Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing.
Bernier J
Crit Rev Oncol Hematol; 2016 Dec; 108():97-108. PubMed ID: 27931845
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
Reynders K; De Ruysscher D
Prog Tumor Res; 2015; 42():67-78. PubMed ID: 26383848
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Immunotherapy for Treatment of Cancer.
Tsun A; Miao XN; Wang CM; Yu DC
Adv Exp Med Biol; 2016; 909():241-83. PubMed ID: 27240460
[TBL] [Abstract][Full Text] [Related]
17. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
18. Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.
Muraro E; Furlan C; Avanzo M; Martorelli D; Comaro E; Rizzo A; Fae' DA; Berretta M; Militello L; Del Conte A; Spazzapan S; Dolcetti R; Trovo' M
Front Immunol; 2017; 8():1476. PubMed ID: 29163540
[TBL] [Abstract][Full Text] [Related]
19. Immuno-oncology combinations: a review of clinical experience and future prospects.
Antonia SJ; Larkin J; Ascierto PA
Clin Cancer Res; 2014 Dec; 20(24):6258-68. PubMed ID: 25341541
[TBL] [Abstract][Full Text] [Related]
20. Immuno-oncology combinations: raising the tail of the survival curve.
Harris SJ; Brown J; Lopez J; Yap TA
Cancer Biol Med; 2016 Jun; 13(2):171-93. PubMed ID: 27458526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
